DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury.
Metab Brain Dis
; 32(5): 1395-1402, 2017 10.
Article
in En
| MEDLINE
| ID: mdl-28303450
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Neuroprotective Agents
/
Brain Injuries, Traumatic
/
Nervous System Diseases
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Metab Brain Dis
Journal subject:
CEREBRO
/
METABOLISMO
Year:
2017
Document type:
Article
Affiliation country: